Our Heritage -
University of Oxford
Excellence in Neuropathology, Neuroimaging and the Healthcare sector.
An 8-year collaboration between Dr Steven Chance (neuroscience and pathology) and Prof. Mark Jenkinson (Neuroimaging) has resulted in the development of the Cortical Disarray Measurement (CDM). This is our core platform technology, initially applied to the diagnosis of Alzheimer’s disease but with the potential to be used to identify other brain conditions as the company grows and expands into new markets.